Stanford V regimen

An abbreviation for a chemotherapy combination that is used to treat Hodgkin lymphoma and is being studied in the treatment of other types of cancer. It includes the drugs mechlorethamine, doxorubicin hydrochloride, vinblastine sulfate, vincristine sulfate, bleomycin sulfate, etoposide phosphate, and prednisone and was developed at Stanford University. Also called Stanford V.